[
    [
        {
            "time": "",
            "original_text": "智飞生物：四价/九价HPV疫苗、五价轮状疫苗将成为近三年业绩保障",
            "features": {
                "keywords": [
                    "智飞生物",
                    "四价HPV疫苗",
                    "九价HPV疫苗",
                    "五价轮状疫苗",
                    "业绩保障"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物：四价/九价HPV疫苗、五价轮状疫苗将成为近三年业绩保障",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "智飞生物：预计明年四价HPV疫苗接种紧张状况将得到一定缓解",
            "features": {
                "keywords": [
                    "智飞生物",
                    "四价HPV疫苗",
                    "接种紧张",
                    "缓解"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "智飞生物：预计明年四价HPV疫苗接种紧张状况将得到一定缓解",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【高管面对面直播】智飞生物：“市场+研发”双轮驱动的疫苗民营龙头",
            "features": {
                "keywords": [
                    "智飞生物",
                    "市场+研发",
                    "双轮驱动",
                    "疫苗",
                    "民营龙头"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【高管面对面直播】智飞生物：“市场+研发”双轮驱动的疫苗民营龙头",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]